1. Prognostic importance of prostate specific antigen for monitoring patients with stages B2 to D1 prostate cancer;Killian;Cancer Res,1985
2. Consensus statement;Cox;Int J Radiat Oncol Biol Phys,1997
3. Fleming I, Cooper J, Henson D; et al. eds. Prostate. In: AJCC cancer staging manual. Philadelphia, New York: Lippincott-Raven; 1997. p. 219–224.
4. Defining the appropriate radiation dose for pretreatment PSA < 10 ng/ml prostate cancer;Pinover;Int J Radiat Oncol Biol Phys,2000
5. ICRU Report No. 50. International Commission on Radiation Units and Measurements: Prescribing, Recording, and Reporting Photon Beam Therapy. Washington, D.C.: International Commission on Radiation Units and Measurements; 1993.